Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients

Chloé Médrano, Lucie Obéric, Florent Puisset, Christian Récher, Delphine Larrieu‐Ciron, Loïc Ysebaert, Caroline Protin, Muriel Picard, Sophie Perriat, Étienne Chatelut,

Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 20 citations · 17 references

Concepts

Abstract

= 41) developed extra-renal toxicity (leading to the death of two patients) despite early administration. Thus, severe toxicity and death can occur whether or not glucarpidase is administered, which confirms the need for further interventional studies to provide greater precision on its role in the management of HD-MTX toxicity.

References

17